And one of the reasons why IIQ is a great long term investment. Low SOI for a biotech at this stage of development (and with multiple products).
Once potential investors do the revenue to EBIT calcs and look at the possible earnings per share, the future potential share price is eye-watering.
Ann: INOVIQ and Promega announce Global Joint Marketing Agreement, page-13
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.0¢ |
Change
0.010(1.75%) |
Mkt cap ! $63.96M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 58.0¢ | 56.5¢ | $44.48K | 76.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3100 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 17159 | 3 |
View Market Depth
| Last trade - 13.07pm 17/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |